The Department of Health and Social Care and ADRES, the entity that manages resources in the health system, announced the purchase of 2000 treatments for hepatitis C patients. According to the results obtained in patients 12 weeks after completing the treatment, there was a cure rate of 99.8%.
The medicines were purchased through the Pan American Health Organization (PAHO) and negotiated with the laboratory for a price of US$ 6,000,900, a saving of 17% over last year’s price.
The Ministry of Health has implemented a centralized procurement mechanism for hepatitis C drugs since 2017, and has benefited 776 patients in 2021; 937 patients in 2022, and more than 483 patients in 2023 so far.
Also read: (Invima raises alarm over stolen Dolex children)
Both contributory and subsidized patients can receive treatment provided they meet the requirements set out in Resolution No. 1692 of 2017 issued by the Ministry of Health and Social Security, which established the following Guidelines for the Allocation and Supply of Hepatitis Drugs C:
• The patient must have a prescription for the drug in MIPRES (a technical tool implemented by the Ministry of Health and Social Security to ensure access to health technology information, prescription reporting, supply verification, control, payment and analysis). are not funded by UPC resources and are supplementary services).
• EPS requests the quantity of medicines from the Ministry of Health based on confirmed patients and prescriptions.
• The EPS and IPS perform the checks and provide medications to the patient separately.
• High cost accounts track and monitor patient care based on information reported by EPS.
in other news